Mechanism of Fatigue in Fibromyalgia and Cortical Motor Neuron Dysfunction

NCT ID: NCT06778681

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-18

Study Completion Date

2025-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to test whether cortical motor neuron dysfunction plays a role in the pathogenesis of fatigue in fibromyalgia patients.

The main questions it aims to answer are:

Do fibromyalgia patients have lower v-wave compared to healthy subjects? Does cheering affect V-wave in fibromyalgia patients more than healthy subjects? Researchers will compare the V-waves of fibromyalgia patients with those of healthy subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All volunteers will first undergo the Fatigue Severity Scale (FSS) assessment, grip strength measurement, and a 4-meter walking speed test. Subsequently, V-wave recordings will be performed.

EMG and Force Data Acquisition

Surface EMG from the soleus muscle and force sensor data will be collected at a 2 kHz sampling rate using a data acquisition system (CED 3601 Power 1401 MKII digital-to-analogue converter and CED 1902 Quad System MKIII amplifier). Data analyses will be performed using Spike2 version 7.20 software.

Maximal plantar flexion will be performed against a force platform equipped with a force sensor (FC2231-0000-0100-L Compression Load Sensor, France) mounted on a wall and connected to a data acquisition device. Participants will be fixed to the examination table using a pelvic strap to prevent cranial movement during the contraction. This setup will allow real-time recording of muscle force during the 1-minute isometric contraction.

V-Wave Measurement Procedure

The procedure involves positioning participants prone on an examination table. Two self-adhesive Ag/AgCl surface electrodes (KENDALL® Coviden, Massachusetts, USA) will be placed on the belly of the left lateral soleus muscle with a 4 cm inter-electrode distance. A grounding electrode will be placed over the malleolus.

Before attaching the electrodes, any hair on the skin will be shaved, and the skin will be cleaned with alcohol wipes to remove surface oils. An ECG gel will be applied to increase skin conductivity.

For the V-wave measurement:

A cathode electrode (1 cm diameter round electrode) will be positioned over the tibial nerve in the left popliteal fossa, and an anode electrode (10x10 cm) will be placed over the suprapatellar area.

Stimulation will be delivered using a constant-current stimulator \[model DS7A, Digitimer Ltd, Hertfordshire, UK\] with monophasic rectangular current pulses of 1 ms duration.

The current intensity will start at 5 mA and incrementally increase. The intensity required to achieve the recruitment curve of the H-reflex and the maximum M-response (Mmax) will be determined. Supramaximal stimulation at 1.2 times the Mmax intensity will be applied to record the V-wave response.

Recording of V-Wave Responses

A one-minute fatigue protocol will be applied to see the effect of Cheer on fatigue. For this purpose, V responses will be recorded during maximum voluntary plantar flexion maintained for 60 seconds. Four V-wave responses will be recorded during the 3rd, 20th, 40th and 60th seconds of contraction. Before 60th second measurement, maximal voluntary contraction will be accompanied by verbal encouragement ("push, push, push") and clapping. Supramaximal stimulation will be given during specified times to measure v-wave.

Sample size calculation

For the V-wave measurements, repeated measures analysis of variance (ANOVA) will be used to analyze the four measurements within the two groups. Assuming a medium effect size (partial eta squared = 0.06), an alpha error level of 0.05, and a power of 0.95, the minimum required sample size was calculated to be 18 participants per group, resulting in a total of 36 participants.

The sample size calculation was performed using G\*Power software version 3.1.9.4 (Franz Faul, University of Kiel, Germany).

Statistical Analysis

The normality of data distribution will be assessed using the Shapiro-Wilk test. Continuous numerical variables will be summarized as mean and standard deviation, while categorical variables will be presented as frequencies (percentages).

If the data follow a normal distribution, V-wave amplitudes will be compared using repeated measures analysis of variance (ANOVA). In cases where the analysis yields a p-value \< 0.05, post-hoc pairwise comparisons will be conducted to identify differences in V-wave responses obtained during different stimulations.

If the data does not follow a normal distribution, within-group comparisons will be performed using the Friedman test and Wilcoxon test, while between-group comparisons will be performed using the Mann-Whitney U test. Post-hoc pairwise comparisons will be evaluated with Bonferroni-adjusted p-values, where a corrected p-value \< 0.05 will be considered statistically significant.

All analyses will be conducted using SPSS software version 18.0.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fibromyalgia

Subjects with diagnosed fibromyalgia will be in this arm. Subjects will have their grip strength and 4-meter walking speed measured and will be asked to fill the fatigue severity scale.

Subjects will be tested for v-wave during voluntary foot plantarflexion.

Group Type EXPERIMENTAL

Cheer

Intervention Type OTHER

During voluntary muscle contraction subjects will be cheered with verbal encouragement ("push, push, push") and clapping.

Healthy

Healthy subjects will be in this arm. Subjects will have their grip strength and 4-meter walking speed measured and will be asked to score the fatigue severity scale.

Subjects will be tested for v-wave during voluntary foot plantarflexion.

Group Type EXPERIMENTAL

Cheer

Intervention Type OTHER

During voluntary muscle contraction subjects will be cheered with verbal encouragement ("push, push, push") and clapping.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cheer

During voluntary muscle contraction subjects will be cheered with verbal encouragement ("push, push, push") and clapping.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with fibromyalgia according to acr 2016 criteria(for fibromyalgia group)
* Being healthy(for control group)
* 18-60 years old
* Volunteering
* Being female
* Right hand dominant

Exclusion Criteria

* Presence of scars, dermatitis, or similar conditions on the skin where surface EMG electrodes will be placed.
* Diseases causing muscle and nerve dysfunction: myopathies, polyneuropathy, radiculopathy, peripheral nerve lesions such as entrapment neuropathies; central nervous system disorders such as stroke, amyotrophic lateral sclerosis, multiple sclerosis, and parkinsonism.
* Hypertension and cardiac arrhythmias.
* Other diseases with fatigue symptoms: cardiopulmonary diseases, hypothyroidism, polymyalgia rheumatica, major depression, bipolar disorder, chronic fatigue syndrome.
* Epilepsy
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fuat Orhun Alayoglu

Resident Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Physical Medicine Rehabilitation Training &amp; Research Hospital

Istanbul, Bahçelievler, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/438

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effectiveness Of BETY In Fibromyalgia
NCT07034417 NOT_YET_RECRUITING NA
Craniovertebral Angle and Fibromyalgia Severity
NCT06957873 ENROLLING_BY_INVITATION